secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001178913-24-000726
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward reports record 2023 revenue $13.9M; Q4 rev $6.9M; FY2024 guidance $28-32M
--------------------------------------------------------------------------------

- Record annual revenue $13.9M for FY2023, up 151% from $5.5M in FY2022.
- Q4 2023 revenue $6.9M (+216% YoY); GAAP net loss $5.6M ($0.13/sh), adjusted net loss $3.3M ($0.05/sh).
- Integration of ReWalk and AlterG complete; expected $3M in annual net savings in 2024.
- CMS finalized Home Health Rule including exoskeletons in Medicare brace benefit effective Jan 1, 2024.
- FY2024 revenue guidance $28-32M; non-GAAP gross margin high 40s%; Q1 2024 rev $5.0-5.5M (no Medicare revenue).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324000726/0001178913-24-000726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324000726/zk2431056.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-000726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer